Armanni-Ebstein Lesions in Terminal Hyperglycemia

Area of Science:

• Forensic Pathology
• Endocrinology
• Diabetology

Background:

• Armanni-Ebstein lesions (AEL) are histopathological findings associated with uncontrolled diabetes mellitus.
• The precise relationship between AEL and terminal hyperglycemia requires further elucidation.

Purpose of the Study:

• To investigate the association between Armanni-Ebstein lesions and terminal hyperglycemia in postmortem cases.
• To explore potential contributing factors, such as ketoacidosis, in the development of AEL.

Main Methods:

• Retrospective analysis of 71 cases with vitreous glucose levels ≥11.1 mmol/L.
• Comparison of vitreous glucose levels, dehydration, renal failure, osmolality, and β-hydroxybutyrate levels between cases with and without AEL.

Main Results:

• No significant difference in vitreous glucose levels was observed between cases with AEL (n=27) and those without (n=44).
• Significantly higher levels of β-hydroxybutyrate were found in cases with AEL, suggesting a role for ketoacidosis.
• No significant differences in dehydration, renal failure, or osmolality were noted.

Conclusions:

• Terminal hyperglycemia alone may not be the sole determinant for AEL development.
• Ketoacidosis, evidenced by elevated β-hydroxybutyrate, appears to be a significant factor facilitating AEL formation.
• Findings suggest that the correlation observed in animal studies may not directly translate to human cases of AEL.